Labiotech.eu

Discover how UCB's pipeline strategy in 2026 is still focused on its core areas of immunology and neurology. The post UCB's pipeline strategy in 2026: Doubling down on immunology and neurology appeared first on Labiotech.eu. Labiotech UG and Labiotech.eu.

In this article, we take a look at seven clinical-stage biotechs that are fostering R&D in the Duchenne muscular dystrophy therapeutic space. The post Seven biotechs driving progress in Duchenne muscular dystrophy appeared first on Labiotech.eu. Labiotech

The CBO CEO relationship shapes biotech deal success. Discover insights from 19 industry leaders on board alignment and partnering. The post We asked 19 biotech leaders what breaks their deals. It wasn't the science. appeared first on Labiotech.eu. Labiot

The top biotech deals of July 2026 were over small molecules, cell therapies, antibodies, RNA therapeutics, vaccines, and AI. The post Top biotech deals in July 2026 appeared first on Labiotech.eu. Labiotech UG and Labiotech.eu. Unauthorized use and/or du

The CEO of Therorna discusses the science of behind circular RNA and why Western pharma hasn't paid enough attention to what's being built in China. The post Why Western pharma is sleeping on China's circular RNA revolution appeared first on Labiotech.eu.

The companies BridgeBio, Erasca, Chai Discovery, and MeiraGTx bagged the biggest biotech funding rounds overall in July 2026. The post The biggest biotech funding rounds in July 2026 appeared first on Labiotech.eu. Labiotech UG and Labiotech.eu. Unauthori

We look at some of the top companies that are investigating CAR-T therapies in clinical trials for autoimmune diseases. The post Eight CAR-T companies tackling autoimmune disorders appeared first on Labiotech.eu. Labiotech UG and Labiotech.eu. Unauthorize

Learn why cryopreservation is becoming essential for scalable, standardized cell therapy manufacturing and commercialization. The post Cryopreservation in cell therapy: Reducing variability from the start appeared first on Labiotech.eu. Labiotech UG and L

While Japan historically lacked foreign investment, the field is becoming more dynamic. Discover ten essential biotech companies in Japan. The post 10 biotechs in Japan to watch in 2026 appeared first on Labiotech.eu. Labiotech UG and Labiotech.eu. Unauth

Delve into what Merck has planned for the future of its pipeline as Keytruda's patent is getting closer to expiry. The post Merck after Keytruda: what the pipeline looks like appeared first on Labiotech.eu. Labiotech UG and Labiotech.eu. Unauthorized use